Do, Thien Phu
la Cour Karottki, Nikolaj Folke
Ashina, Messoud
Article History
Accepted: 4 October 2021
First Online: 11 December 2021
Compliance with Ethical Standards
:
: Not applicable.
: Not applicable.
: Not applicable.
: Messoud Ashina has received personal fees from AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis and Teva Pharmaceuticals. He is the principal investigator for ongoing clinical trials for AbbVie/Allergan, Amgen, and Lundbeck. He has received research grants from Lundbeck Foundation, Novo Nordisk Foundation, and Novartis. He serves as associate editor of Cephalalgia, The Journal of Headache and Pain, and Brain. He is the current President of the International Headache Society. Thien Phu Do and Nikolaj Folke la Cour Karottki report no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.